Optimizing pegaspargase therapy in patients with hypersensitivity reactions

Divya Subburaj; Ketan Kulkarni; Tamara MacDonald

doi:10.1080/10428194.2022.2086251

Optimizing pegaspargase therapy in patients with hypersensitivity reactions

Divya Subburaj, Ketan Kulkarni, Tamara MacDonald

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	2727-2730
Number of pages	4
Journal	Leukemia and Lymphoma
Volume	63
Issue number	11
DOIs	https://doi.org/10.1080/10428194.2022.2086251
Publication status	Published - 2022
Externally published	Yes

ASJC Scopus Subject Areas

Hematology
Oncology
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1080/10428194.2022.2086251

Cite this

@article{75a25e4686e144b7886269ed93a3c8a3,

title = "Optimizing pegaspargase therapy in patients with hypersensitivity reactions",

author = "Divya Subburaj and Ketan Kulkarni and Tamara MacDonald",

year = "2022",

doi = "10.1080/10428194.2022.2086251",

language = "English",

volume = "63",

pages = "2727--2730",

journal = "Leukemia and Lymphoma",

issn = "1042-8194",

publisher = "Informa Healthcare",

number = "11",

}

TY - JOUR

T1 - Optimizing pegaspargase therapy in patients with hypersensitivity reactions

AU - Subburaj, Divya

AU - Kulkarni, Ketan

AU - MacDonald, Tamara

PY - 2022

Y1 - 2022

UR - http://www.scopus.com/inward/record.url?scp=85132777853&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85132777853&partnerID=8YFLogxK

U2 - 10.1080/10428194.2022.2086251

DO - 10.1080/10428194.2022.2086251

M3 - Letter

C2 - 35727258

AN - SCOPUS:85132777853

SN - 1042-8194

VL - 63

SP - 2727

EP - 2730

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

IS - 11

ER -

Optimizing pegaspargase therapy in patients with hypersensitivity reactions

ASJC Scopus Subject Areas

UN SDGs

Access to Document

Other files and links

Cite this